查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088738

胃腸病門診手術中心市場：按服務、適應症、醫療級別、患者群體、應用、最終用戶和所有權分類——2026-2032年全球市場預測

Gastroenterology Ambulatory Surgery Center Market by Services, Indication, Level of Care, Patient Demographic, Application, End-User, Ownership - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，胃腸病門診手術中心市場將成長至 135.5 億美元，複合年成長率為 8.59%。

主要市場統計數據
基準年 2025 76億美元
預計年份：2026年 82.1億美元
預測年份 2032 135.5億美元
複合年成長率 (%) 8.59%

隨著內視鏡檢查、大腸鏡檢查、上消化道檢查及相關微創手術等適宜性檢查從醫院門診部轉移到醫療系統內專科的、非緊急的醫療機構，胃腸病門診手術中心（GI ASC）市場的戰略重要性日益凸顯。推動這一需求成長的因素包括：全球胃腸道疾病和大腸癌負擔加重、預防性篩檢的普及、人口老齡化以及保險公司在控制手術成本的同時提高醫療服務可及性的壓力。

檢驗的公共衛生數據證實了臨床需求的規模。世界衛生組織（WHO）國際癌症研究機構（IARC）報告稱，2022年大腸直腸癌是全球整體最常見的癌症之一，新增病例約190萬例，死亡人數超過90萬人。在美國，美國癌症協會估計每年新增大腸直腸癌病例超過15萬例，而美國預防服務工作小組（USPSTF）則建議對平均風險族群從45歲開始進行篩檢。這種基於實證醫學的篩檢政策轉變正在增加檢測數量，並加強高效的消化器官系統門診手術中心（ASC）網路的作用。

對於投資者、營運商、保險公司和醫療設備相關人員，該領域的特點包括：高通量診斷、持續後續觀察的需求、麻醉和感染控制要求，以及數位化預約系統、電子健康記錄、人工智慧大腸鏡檢查和品質分析的日益普及。競爭優勢越來越依賴與醫生的合作、認證準備情況、卓越的內視鏡再處理流程、與保險公司的合約、患者體驗以及可衡量的臨床質量，例如腺瘤檢出率、盲腸插入率、併發症追蹤和病理結果的及時隨訪。

消化器官系統道門診手術中心（ASC）格局的變革性變化

由於診療地點的轉移、篩檢指南的擴展以及門診手術流程的產業化，消化器官系統門診手術中心（ASC）的格局正在轉變。聯邦醫療保險和私人保險公司早已認知到，門診手術中心（ASC）能夠以通常低於醫院門診部的支付標準提供某些手術，這使得ASC成為基於價值的醫療保健策略的核心。大腸鏡檢查和上消化道內視鏡檢查仍然是高流量且遵循既定流程的手術，這使得胃腸病學成為最適合ASC模式的專科之一。

人工智慧對消化器官系統ASCs的累積影響

人工智慧 (AI) 正在重塑胃腸病門診手術中心 (ASC) 的累積經濟效益和臨床結果。其中最突出的應用是 AI 輔助大腸鏡檢查，特別是設計用於即時識別潛在息肉的電腦輔助檢測系統。經過同行評審的隨機對照試驗和Meta分析表明，AI 輔助大腸鏡檢查可以提高腺瘤檢出率，而腺瘤檢出率是與大腸直腸癌預防相關的關鍵品質指標。

亞太、北美、歐洲和新興市場的關鍵區域洞察

北美仍然是胃腸門診手術中心發展最成熟的區域，其中美國處於領先地位，透過其門診手術中心（ASC）報銷機制、醫生所有製模式、與私人保險公司簽訂的合約以及不斷擴大的結直腸癌篩檢，建立了完善的門診內鏡檢查基礎設施。同時，加拿大的公共醫療保健系統則呈現不同的發展模式，其重點在於縮短等待時間、建立醫院內視鏡檢查設施以及進行省級篩檢計畫。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約市場的關鍵群體特定見解。

東協是消化器官系統手術中心（ASC）多元化發展的走廊。新加坡、馬來西亞、泰國、印尼、越南和菲律賓在私人醫療保健發展、內視鏡普及和癌症篩檢推廣方面處於不同的階段。雖然都市區對門診診斷的需求日益成長，但農村地區更需要醫療專業人員、更完善的轉診系統以及價格合理的篩檢途徑。

對主要胃腸病學門診手術中心市場進行國別分析。

美國在獨立和連鎖胃腸病門診手術中心（ASC）方面處於主導地位。這得歸功於保險公司對低成本醫療服務場所的需求、大規模的私人保險用戶以及45歲開始的篩檢指南。加拿大專注於省級准入管理和縮短等待時間，而墨西哥則將私人門診服務的成長與跨境醫療服務的機會相結合。巴西擁有拉丁美洲規模最大的醫療保健系統，預計其私人內視鏡網路也將成長，儘管醫療服務取得方面仍存在差距。

為胃腸道門診手術中心行業的領導者提供的實用建議

產業領導者應優先考慮產能規劃，以預測大腸直腸癌篩檢、糞便大便潛血試驗試驗陽性患者的後續檢查、後續觀察大腸鏡檢查以及上消化道診斷的需求。能夠維持預約流程精簡、提高腸道灌洗完成率和快速提供病理結果的醫療機構，可以提升臨床品質和資源利用率。

檢驗的消化系統ASC市場資訊調查方法

檢驗的胃腸道門診手術中心市場情報以系統化的調查方法為支撐，該方法結合了二手資料研究、一手檢驗和分析三角驗證。二級資訊來源包括公共衛生資料集、監管指南、報銷標準、癌症篩檢建議、產業申報資料、同儕審查的臨床文獻、認證標準，以及世界衛生組織 (WHO)、國際癌症研究機構 (IARC)、經濟合作暨發展組織 (OECD)、美國疾病管制與預防中心 (CDC)、美國預防服務工作組 (USPSTF)、美國醫療保險和醫療補助衛生署）和醫療補助機構醫療保健機構的醫療保健機構（CMS

結論：消化系統ASC將在未來的消化系統健康中發揮核心作用。

隨著醫療保健系統致力於早期癌症檢測、降低門診治療成本和改善患者就診途徑，胃腸病門診手術中心市場預計將保持其重要性。大腸直腸癌篩檢、人口老化、胃腸道疾病負擔以及保險公司對患者轉診至合適治療地點的支持，仍然是推動市場需求的關鍵因素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：胃腸病門診手術中心市場：依服務類型分類

  • 診斷服務
    • 膠囊內視鏡
    • 大腸鏡檢查
    • 食道壓力測量
    • 乙狀結腸鏡檢查
    • 上消化道內視鏡檢查
  • 外科服務
    • 減重手術
    • 膽囊切除術
    • 大腸直腸/直腸手術
    • 腹股溝疝氣修補手術
    • 腹腔鏡胃腸手術
    • 括約肌切開術
  • 治療服務
    • 內視鏡黏膜切除術
    • 內視鏡黏膜下剝離術
    • 痔瘡結紮術
    • 息肉切除術
    • 硬化療法

第8章：胃腸病門診手術中心市場：依適應症分類

  • 大腸直腸癌篩檢
  • 胃腸道感染疾病
  • 發炎性腸道疾病
  • 肝硬化

第9章：胃腸病門診手術中心市場：依醫療級別分類

  • 觀察
  • 門診手術

第10章：胃腸病門診手術中心市場：依病患特徵分類

  • 成人
  • 老年人
  • 兒童

第11章：胃腸病門診手術中心市場：依應用領域分類

  • 診斷測試
  • 內視鏡檢查
  • 治療性介入

第12章：胃腸病門診手術中心市場：依最終用戶分類

  • 診所和私人診所
  • 醫院
  • 獨立ASC

第13章：胃腸病門診手術中心市場：依所有權類型分類

  • 公司所有權
  • 獨立的
  • 醫院附屬

第14章：胃腸病門診手術中心市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章：胃腸病門診手術中心市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：胃腸病門診手術中心市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Alabama Digestive Health Endoscopy Center（AL）
  • Alfa Surgery Center, LLC
  • Athens Gastroenterology Center
  • Baptist Health South Florida, Inc.
  • Covenant Physician Partners
  • Envision Healthcare Corporation
  • Gastro Health LLC
  • Gastroenterology Associates Endoscopy Center
  • GE HealthCare Technologies Inc.
  • Gulf Coast Endoscopy Center
  • HCA Healthcare, Inc.
  • Inova McLean Ambulatory Surgery Center
  • Jupiter Outpatient Surgery Center, LLC
  • Liberty Endoscopy Center
  • OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
  • Ohio Gastroenterology Group Inc.
  • Ontario Advanced Surgery Center
  • Regent Surgical
  • SCA Health
  • Shelby Ambulatory Surgery
  • SOUTH BROWARD ENDOSCOPY, LLC
  • Tenet Healthcare Corporation
  • The Outpatient Center of Boynton Beach
  • United Digestive
  • Universal Health Services, Inc.
Product Code: MRR-B9334AD6C1A9

The Gastroenterology Ambulatory Surgery Center Market is projected to grow by USD 13.55 billion at a CAGR of 8.59% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.60 billion
Estimated Year [2026] USD 8.21 billion
Forecast Year [2032] USD 13.55 billion
CAGR (%) 8.59%

The gastroenterology ambulatory surgery center (GI ASC) market is gaining strategic importance as healthcare systems shift appropriate endoscopy, colonoscopy, upper GI procedures, and related minimally invasive interventions from hospital outpatient departments to specialized, lower-acuity sites of care. Demand is supported by the global burden of digestive disease and colorectal cancer, the expansion of preventive screening, aging populations, and payer pressure to improve access while controlling procedural costs.

Verified public health data reinforce the scale of clinical need. The World Health Organization's International Agency for Research on Cancer reported colorectal cancer among the world's most common cancers in 2022, with approximately 1.9 million new cases and more than 900,000 deaths globally. In the United States, the American Cancer Society continues to estimate more than 150,000 new colorectal cancer cases annually, while the U.S. Preventive Services Task Force recommends average-risk screening beginning at age 45. These evidence-based screening shifts increase procedural volumes and strengthen the role of efficient GI ASC networks.

For investors, operators, payers, and medical device stakeholders, the sector is defined by high-volume diagnostics, recurring surveillance needs, anesthesia and infection-control requirements, and growing adoption of digital scheduling, electronic health records, AI-assisted colonoscopy, and quality analytics. Competitive advantage increasingly depends on physician alignment, accreditation readiness, endoscope reprocessing excellence, payer contracting, patient experience, and measurable clinical quality such as adenoma detection rate, cecal intubation rate, complication tracking, and timely pathology follow-up.

Transformative Shifts in the GI ASC Landscape

The GI ASC landscape is being transformed by site-of-care migration, screening guideline expansion, and the industrialization of outpatient procedural workflows. Medicare and commercial payers have long recognized that ambulatory surgery centers can deliver selected procedures at payment rates that are generally below hospital outpatient department rates, making ASCs central to value-based care strategies. As colonoscopy and upper endoscopy remain high-volume, protocol-driven procedures, gastroenterology is one of the specialties most suited to the ASC model.

A second major shift is the broadening of colorectal cancer screening eligibility. The USPSTF recommendation to begin average-risk screening at age 45 expanded the addressable screening population in the United States, while organized screening programs in Europe and parts of Asia-Pacific continue to increase participation. Positive stool-based tests also create downstream demand for diagnostic colonoscopy, reinforcing the need for capacity planning across ASC networks.

Operationally, GI ASCs are moving from physician-office extensions to data-enabled procedural platforms. Leading centers are standardizing bowel preparation outreach, pre-anesthesia assessment, turnover time management, endoscope reprocessing documentation, supply utilization, pathology coordination, and patient navigation. This shift favors scaled operators with strong compliance infrastructure, cybersecurity controls, revenue cycle discipline, and the ability to demonstrate quality outcomes to payers and referring physicians.

Cumulative Impact of Artificial Intelligence on GI ASCs

Artificial intelligence is beginning to reshape the cumulative economics and clinical performance of gastroenterology ambulatory surgery centers. The most visible use case is AI-assisted colonoscopy, particularly computer-aided detection systems designed to identify potential polyps in real time. Peer-reviewed randomized trials and meta-analyses have shown that AI-assisted colonoscopy can improve adenoma detection rates, an important quality indicator associated with colorectal cancer prevention.

Beyond the procedure room, AI is expanding into scheduling optimization, no-show prediction, automated patient reminders, documentation assistance, coding support, inventory forecasting, and referral management. These applications matter because GI ASCs depend on high utilization, predictable room turnover, accurate reimbursement, and low cancellation rates. AI-enabled workflow tools can help match procedure duration, anesthesia coverage, staff allocation, and recovery capacity more precisely.

The cumulative impact will be strongest where AI is implemented with governance rather than as a standalone technology purchase. Industry leaders must validate algorithms across patient populations, maintain physician oversight, monitor false positives and workflow interruptions, and comply with privacy and medical device regulations. Centers that integrate AI into quality improvement programs, rather than treating it as a marketing feature, are better positioned to improve detection, throughput, documentation quality, and patient satisfaction.

Key Regional Insights Across Asia-Pacific, North America, Europe, and Emerging Markets

North America remains the most mature regional environment for gastroenterology ambulatory surgery centers, led by the United States, where ASC reimbursement structures, physician ownership models, commercial payer contracting, and expanded colorectal cancer screening have created a broad outpatient endoscopy base. Canada's publicly funded system creates a different growth pattern, with emphasis on wait-time reduction, hospital-affiliated endoscopy capacity, and provincial screening programs.

Europe benefits from organized colorectal cancer screening, strong quality standards, and national health system oversight. The European Union's cancer screening initiatives and country-level fecal immunochemical testing programs support colonoscopy demand, while the United Kingdom, Germany, France, Italy, and Spain continue to invest in endoscopy capacity, workforce training, and infection prevention. Adoption of standalone ASC models varies because reimbursement and ownership rules differ widely across European health systems.

Asia-Pacific is one of the fastest-evolving opportunity zones as China, India, Japan, South Korea, Australia, and ASEAN countries address rising colorectal cancer incidence, aging populations, urban hospital congestion, and expanding private healthcare infrastructure. Latin America shows stronger demand in Brazil and Mexico, although access remains uneven across income groups and urban-rural settings. The Middle East, especially GCC markets, is investing in advanced outpatient facilities and medical tourism, while Africa remains constrained by limited endoscopy capacity, specialist shortages, and lower screening penetration, creating long-term need for scalable, cost-efficient GI services.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO Markets

ASEAN represents a diverse growth corridor for GI ASCs, with Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines at different stages of private healthcare development, endoscopy availability, and cancer screening adoption. Urban centers are seeing stronger demand for outpatient diagnostics, while rural areas require workforce expansion, referral systems, and affordable screening pathways.

The GCC is increasingly attractive due to government-backed healthcare modernization, high investment in specialty clinics, rising metabolic disease burden, and demand for premium outpatient care. Saudi Arabia and the United Arab Emirates are particularly active in private-sector participation and facility modernization, creating opportunities for GI ASC operators, device suppliers, anesthesia providers, and digital health vendors.

The European Union provides a quality-driven environment shaped by screening policy, patient safety regulation, and cross-country benchmarking. BRICS countries offer scale, with China and India contributing large patient volumes, Brazil expanding private healthcare access, Russia maintaining major urban specialty capacity, and South Africa serving as a key African hub. G7 countries combine aging demographics, established reimbursement systems, and early adoption of AI-enabled endoscopy. NATO countries are not a healthcare bloc, but many members emphasize health system resilience, cybersecurity, supply chain security, and emergency preparedness, all of which are increasingly relevant to ASC operations.

Key Country Insights for Major Gastroenterology ASC Markets

The United States leads in independent and chain-affiliated gastroenterology ASCs, supported by payer interest in lower-cost sites of care, a large commercially insured population, and screening guidelines beginning at age 45. Canada focuses on provincial access management and wait-time reduction, while Mexico combines private outpatient growth with cross-border care opportunities. Brazil is Latin America's largest healthcare system by scale and offers growth in private endoscopy networks, though access disparities persist.

In Europe, the United Kingdom continues to expand diagnostic capacity through national cancer pathways and community diagnostic initiatives. Germany has strong specialist infrastructure and high procedural quality expectations, while France maintains structured screening and regulated outpatient care. Italy and Spain show rising demand tied to aging populations and organized screening, whereas Russia's activity is concentrated in major urban medical centers with variable regional access.

In Asia-Pacific, China's scale, aging population, and rising colorectal cancer burden create substantial long-term demand for endoscopy capacity. India is expanding private GI care in metropolitan areas, supported by medical tourism and rising awareness, but affordability remains a constraint. Japan and South Korea have advanced endoscopy practices, aging populations, and high technology adoption. Australia combines public screening programs with private procedural capacity, making it one of the region's more structured outpatient GI markets.

Actionable Recommendations for GI ASC Industry Leaders

Industry leaders should prioritize capacity planning around colorectal cancer screening, positive stool-test follow-up, surveillance colonoscopy, and upper GI diagnostic demand. Centers that reduce scheduling friction, improve bowel preparation completion, and maintain rapid pathology communication can increase both clinical quality and asset utilization.

Operators should invest in measurable quality infrastructure, including adenoma detection rate monitoring, adverse event reporting, reprocessing audits, sedation safety protocols, patient-reported experience measures, and benchmarked physician performance. These metrics support payer negotiations and strengthen referral confidence.

AI should be deployed selectively in areas with validated evidence and clear workflow value. AI-assisted polyp detection, automated documentation, no-show prediction, and revenue cycle analytics can improve performance, but implementation should include data governance, physician oversight, cybersecurity controls, and ongoing outcome measurement.

Growth strategies should combine physician alignment, payer contracting, acquisition discipline, and regional market tailoring. In mature markets, consolidation and operational excellence matter most; in emerging markets, partnerships with hospitals, insurers, and government screening programs can build trust and accelerate adoption.

Research Methodology for Verified GI ASC Market Intelligence

A structured research methodology combining secondary research, primary validation, and analytical triangulation supports verified GI ASC market intelligence. Secondary sources include public health datasets, regulatory guidance, reimbursement references, cancer screening recommendations, industry filings, peer-reviewed clinical literature, accreditation standards, and publications from organizations such as WHO, IARC, OECD, CDC, USPSTF, CMS, national health ministries, and gastroenterology societies.

Primary research is used to validate market assumptions through discussions with gastroenterologists, ASC administrators, payers, device manufacturers, anesthesia service providers, healthcare investors, and digital health vendors. These inputs help assess procedural volume trends, technology adoption, reimbursement dynamics, staffing constraints, quality benchmarks, and regional barriers to outpatient endoscopy expansion.

The final analysis triangulates epidemiology, screening policy, site-of-care economics, installed capacity, competitive intensity, and technology trends. Emphasis is placed on verified data, reproducible assumptions, and practical interpretation for executives evaluating growth, partnership, acquisition, or market-entry decisions in the gastroenterology ambulatory surgery center sector.

Conclusion: GI ASCs Are Central to the Future of Digestive Health

The gastroenterology ambulatory surgery center market is positioned for sustained relevance as healthcare systems seek earlier cancer detection, lower-cost outpatient care, and better patient access. Colorectal cancer screening, aging demographics, digestive disease burden, and payer support for appropriate site-of-care migration remain the core demand drivers.

Competitive differentiation will increasingly depend on quality transparency, operational efficiency, physician engagement, AI-enabled workflow improvement, and regional customization. Mature markets will reward scale and payer sophistication, while emerging markets will reward capacity creation, affordability, workforce development, and trusted clinical governance.

Executives that align clinical excellence with data-backed operations will be best positioned to capture growth. GI ASCs that can prove safety, detection quality, access improvement, and cost efficiency are likely to remain central to the future of digestive health delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Gastroenterology Ambulatory Surgery Center Market, by Services

  • 7.1. Diagnostic Services
    • 7.1.1. Capsule Endoscopy
    • 7.1.2. Colonoscopy
    • 7.1.3. Esophageal Manometry
    • 7.1.4. Flexible Sigmoidoscopy
    • 7.1.5. Upper Endoscopy
  • 7.2. Surgical Services
    • 7.2.1. Bariatric Surgery
    • 7.2.2. Cholecystectomy
    • 7.2.3. Colorectal Surgery
    • 7.2.4. Inguinal Hernia Repair
    • 7.2.5. Laparoscopic Gastrointestinal Surgeries
    • 7.2.6. Sphincterotomy
  • 7.3. Therapeutic Services
    • 7.3.1. Endoscopic Mucosal Resection
    • 7.3.2. Endoscopic Submucosal Dissection
    • 7.3.3. Hemorrhoid Ligation
    • 7.3.4. Polypectomy
    • 7.3.5. Sclerotherapy

8. Gastroenterology Ambulatory Surgery Center Market, by Indication

  • 8.1. Colorectal Cancer Screening
  • 8.2. Gastrointestinal Infections
  • 8.3. Inflammatory Bowel Diseases
  • 8.4. Liver Cirrhosis

9. Gastroenterology Ambulatory Surgery Center Market, by Level of Care

  • 9.1. Observation
  • 9.2. Same-Day Surgery

10. Gastroenterology Ambulatory Surgery Center Market, by Patient Demographic

  • 10.1. Adults
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Gastroenterology Ambulatory Surgery Center Market, by Application

  • 11.1. Diagnostic Tests
  • 11.2. Endoscopy
  • 11.3. Therapeutic Interventions

12. Gastroenterology Ambulatory Surgery Center Market, by End-User

  • 12.1. Clinics & Physicians' Offices
  • 12.2. Hospitals
  • 12.3. Independent ASCs

13. Gastroenterology Ambulatory Surgery Center Market, by Ownership

  • 13.1. Corporation-Owned
  • 13.2. Freestanding
  • 13.3. Hospital-Affiliated

14. Gastroenterology Ambulatory Surgery Center Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Gastroenterology Ambulatory Surgery Center Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Gastroenterology Ambulatory Surgery Center Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Alabama Digestive Health Endoscopy Center (AL)
  • 18.2. Alfa Surgery Center, LLC
  • 18.3. Athens Gastroenterology Center
  • 18.4. Baptist Health South Florida, Inc.
  • 18.5. Covenant Physician Partners
  • 18.6. Envision Healthcare Corporation
  • 18.7. Gastro Health LLC
  • 18.8. Gastroenterology Associates Endoscopy Center
  • 18.9. GE HealthCare Technologies Inc.
  • 18.10. Gulf Coast Endoscopy Center
  • 18.11. HCA Healthcare, Inc.
  • 18.12. Inova McLean Ambulatory Surgery Center
  • 18.13. Jupiter Outpatient Surgery Center, LLC
  • 18.14. Liberty Endoscopy Center
  • 18.15. OHIO GASTROENTEROLOGY & LIVER INSTITUTE and GASTRO HEALTH
  • 18.16. Ohio Gastroenterology Group Inc.
  • 18.17. Ontario Advanced Surgery Center
  • 18.18. Regent Surgical
  • 18.19. SCA Health
  • 18.20. Shelby Ambulatory Surgery
  • 18.21. SOUTH BROWARD ENDOSCOPY, LLC
  • 18.22. Tenet Healthcare Corporation
  • 18.23. The Outpatient Center of Boynton Beach
  • 18.24. United Digestive
  • 18.25. Universal Health Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIAGNOSTIC SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COLONOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COLONOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COLONOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ESOPHAGEAL MANOMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ESOPHAGEAL MANOMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ESOPHAGEAL MANOMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLEXIBLE SIGMOIDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLEXIBLE SIGMOIDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLEXIBLE SIGMOIDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL UPPER ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL UPPER ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL UPPER ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BARIATRIC SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BARIATRIC SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BARIATRIC SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHOLECYSTECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CHOLECYSTECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CHOLECYSTECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COLORECTAL SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COLORECTAL SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COLORECTAL SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INGUINAL HERNIA REPAIR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INGUINAL HERNIA REPAIR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INGUINAL HERNIA REPAIR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LAPAROSCOPIC GASTROINTESTINAL SURGERIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LAPAROSCOPIC GASTROINTESTINAL SURGERIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LAPAROSCOPIC GASTROINTESTINAL SURGERIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPHINCTEROTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPHINCTEROTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPHINCTEROTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL THERAPEUTIC SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL THERAPEUTIC SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL THERAPEUTIC SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC MUCOSAL RESECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC MUCOSAL RESECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC MUCOSAL RESECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEMORRHOID LIGATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEMORRHOID LIGATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEMORRHOID LIGATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POLYPECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POLYPECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POLYPECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SCLEROTHERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SCLEROTHERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SCLEROTHERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COLORECTAL CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INFLAMMATORY BOWEL DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFLAMMATORY BOWEL DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INFLAMMATORY BOWEL DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIVER CIRRHOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIVER CIRRHOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIVER CIRRHOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL OBSERVATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL OBSERVATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL OBSERVATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SAME-DAY SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SAME-DAY SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SAME-DAY SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ADULTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL THERAPEUTIC INTERVENTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL THERAPEUTIC INTERVENTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL THERAPEUTIC INTERVENTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CLINICS & PHYSICIANS' OFFICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CLINICS & PHYSICIANS' OFFICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CLINICS & PHYSICIANS' OFFICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INDEPENDENT ASCS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INDEPENDENT ASCS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INDEPENDENT ASCS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CORPORATION-OWNED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CORPORATION-OWNED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CORPORATION-OWNED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FREESTANDING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL FREESTANDING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL FREESTANDING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HOSPITAL-AFFILIATED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOSPITAL-AFFILIATED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOSPITAL-AFFILIATED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 199. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 205. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 207. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 209. GCC GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 232. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 234. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 236. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 237. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 238. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 240. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 242. G7 GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 243. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 245. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 247. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 248. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 249. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 251. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 253. NATO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 276. CANADA GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 277. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 296. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 297. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 298. BRAZIL GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SURGICAL SERVICES, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY THERAPEUTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY LEVEL OF CARE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY PATIENT DEMOGRAPHIC, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED KINGDOM GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY OWNERSHIP, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY GASTROENTEROLOGY AMBULATORY SURGERY CENTER MARKET SIZE, BY DIAGNOSTIC SERVICES, 2018-2032 (USD MILLION)
  • TABLE 313. GE